Figure 2From: Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus Multivariable logistic regression analyses showing odds ratios for claiming secondary prevention therapy after first myocardial infarction during 2003–2006 for acetylsalicylic acid (ASA), angiotensin-converting enzyme inhibitors or angiotensin-2 receptor blockers (ACEIs/ARBs), β-blockers, clopidogrel, and statins. DM: diabetes mellitus. Analyses were adjusted for age, gender, comorbidity, and concomitant pharmacotherapy.Back to article page